mifepristone linepharma 200 mg tabletti
amring - mifepristonum - tabletti - 200 mg - mifepristoni
sitagliptin ratiopharm 25 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sitagliptin malate - tabletti, kalvopäällysteinen - 25 mg - sitagliptiini
sitagliptin ratiopharm 50 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sitagliptin malate - tabletti, kalvopäällysteinen - 50 mg - sitagliptiini
sitagliptin ratiopharm 100 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sitagliptin malate - tabletti, kalvopäällysteinen - 100 mg - sitagliptiini
sitagliptin krka 25 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - sitagliptin - tabletti, kalvopäällysteinen - 25 mg - sitagliptiini
sitagliptin krka 50 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - sitagliptin - tabletti, kalvopäällysteinen - 50 mg - sitagliptiini
sitagliptin krka 100 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - sitagliptin - tabletti, kalvopäällysteinen - 100 mg - sitagliptiini
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - ruoansulatuskanavan stromal-kasvaimet - muut antineoplastiset aineet, proteiinikinaasin estäjät - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
sitagliptin orion 25 mg tabletti, kalvopäällysteinen
orion corporation - sitagliptin hydrochloride monohydrate - tabletti, kalvopäällysteinen - 25 mg - sitagliptiini